Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Review

Published on 02 Jul 2025

Regulation of anti-tumour effects of Paris polyphylla saponins via ROS: molecular mechanisms and therapeutic potentials

in Pharmacology of Anti-Cancer Drugs

Jia Liu
Yongping Mu
Ke Qi
Jiayi Li
Yang Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611911

888 views

Original Research

Accepted on 01 Jul 2025

The functional roles of deoxyelephantopin potential target circTNPO3 in regulating pancreatic cancer malignant phenotype and gemcitabine chemoresistance via miR-188-5p/CDCA3/TRAF2-mediated remodeling of NF-κB signaling pathway

in Pharmacology of Anti-Cancer Drugs

Daolin Ji
Jia Liu
Yanhui Zhang
Li Hou
Haonan Feng
Xue Xing
Deming Guan
Tiangang Cui
Yi Xu
Gang Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1613560

171 views

Review

Published on 01 Jul 2025

Curcumin, EGCG and apigenin in cervical cancer: mechanistic insights and therapeutic potential

in Pharmacology of Anti-Cancer Drugs

Abdulaziz Asiri
Bayan T. Bokahri
Sadaf
Alaa Abdulaziz Eisa
Hashim M. Aljohani
Wesam Nofal
Tahreem Kausar
Mohammad Zeeshan Najm

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592395

1,127 views

Original Research

Accepted on 30 Jun 2025

Quercetin inhibits the cAMP/PKA/CREB/glycolysis axis to exert anti-acute lymphoblastic leukemia effects

in Pharmacology of Anti-Cancer Drugs

Qiuling Ma
Wenqing Liu
Yajing Su
Jue Guo
Man Zhang
Jiayuan Guo
Mingxin Liu
Wenbo Dong
Mingwei Li
Bo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1614973

147 views

Case Report

Published on 30 Jun 2025

Potential interactions between traditional Chinese medicine and osimertinib: a Case Report

in Pharmacology of Anti-Cancer Drugs

Min Zhang
Huiwen Ma
Wanyi Chen
Zhongzhen Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596913

815 views

Original Research

Published on 30 Jun 2025

Characterization of lysine crotonylation-related lncRNAs for prognostic assessment and immune response in glioma

in Pharmacology of Anti-Cancer Drugs

Miaomiao Song
Juan Xu
Zhonghao Gui
Yun Wu
Feifei Wang
Hongmei Sheng
Xueyong Huang
Junyu Qian
Haotian Qin
Ying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573694

867 views

Original Research

Published on 30 Jun 2025

Exploration of M2 macrophage-related biomarkers and a candidate drug for glioblastoma using high-dimensional weighted gene co-expression network analysis

in Pharmacology of Anti-Cancer Drugs

Suyin Feng
Long Zhu
Jinyuan Gu
Kun Kou
Yongtai Liu
Guangmin Zhang
Hua Lu
Honglai Zhang
Runfeng Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1587258

878 views

Brief Research Report

Accepted on 27 Jun 2025

Comparison of associations suggests mainly distinct pools of genetic risk factors contribute to cisplatin-induced hearing loss and hearing difficulty in the general population

in Pharmacology of Anti-Cancer Drugs

Mohammad Shahbazi
Heather E. Wheeler
Xindi Zhang
Robert D. Frisina
Lois B. Travis
M. Eileen Dolan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1577072

386 views

Original Research

Published on 27 Jun 2025

Glycyrrhiza uralensis Fisch. suppresses cell migration via ROS and JAK/STAT signalling pathways in Drosophila

in Pharmacology of Anti-Cancer Drugs

Fangfei Zhou
Qingge Lu
Lingyu Kong
Sitong Wang
Haixia Zhang
Meng Zhao
Yue Hu
Fanwu Wu
Chenxi Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549920

658 views

Original Research

Published on 26 Jun 2025

Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy

in Pharmacology of Anti-Cancer Drugs

Lisanne Koll
Harm Jan Lourens
Glenn Marsman
Stan de Haan
Toshiro Niki
Gerwin A. Huls
Edwin Bremer
Valerie R. Wiersma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1601235

878 views

Original Research

Accepted on 25 Jun 2025

BCL6 Promotes the Progression of High-Grade Serous Ovarian Cancer Cells by Inhibiting PLAAT4

in Pharmacology of Anti-Cancer Drugs

An Wan
Wei-Dong Zhao
Gang Chen
Cheng Peng
Jinhui Tao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1634995

163 views

Case Report

Accepted on 25 Jun 2025

Spermatocytic Tumor Associated With Metastases: Report of a Rare Case and Literature Review

in Pharmacology of Anti-Cancer Drugs

Jianbai Chen
Xiaorong Mou
Zhiming Zhang
Wei Zhang
Zhiyong Nie
Xiaoping Gao
Yanyao Gao
Jianxin Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1636142

102 views

Original Research

Published on 24 Jun 2025

Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess

in Pharmacology of Anti-Cancer Drugs

Weimin Gao
Zhigang Xia
Tingfeng Zhou
Youlin Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602276

744 views

Original Research

Published on 24 Jun 2025

CircASH1L inhibits ferroptosis and enhances cisplatin resistance by sponging miR-515-5p to regulate cell cycle-related CDCA7/RRM2 in ovarian cancer cells

in Pharmacology of Anti-Cancer Drugs

Lu Feng
Xinru Zou
Longyu Tang
Yijun Yuan
Tianwen He
Bin Su
Ying Tang
Jiang Wang
Kang Liu
Jun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563869

885 views

Review

Accepted on 23 Jun 2025

CXCR3 inhibitors for Therapeutic Interventions: Current status and perspectives

in Pharmacology of Anti-Cancer Drugs

Dan Zhou
Rongrong Huo
Yu Jiang
Li Zhang
Shufang Du

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1556196

182 views

Original Research

Accepted on 23 Jun 2025

Spatial deciphering the transcriptomic heterogeneity of tumor spread through air space in lung cancer

in Pharmacology of Anti-Cancer Drugs

Wenhao Wang
Wenhao Zhou
Jingli Fan
Tao Jiang
Guang Yang
Congcong Song
Siwei Xu
Haitao Luo
Huining Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1567527

153 views